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center in the implantation of a single endograft type, with
emphasis on routine ultrasound scan interrogation. These
preliminary observations may ultimately help define the
future strategy of endoleak diagnosis and management.
Postoperative surveillance with computed tomographic
(CT) scan or color duplex ultrasound (CDU) scan has
been used in the detection of endoleak.5 At this point, the
best method and frequency of diagnostic study for endo-
graft surveillance have been undefined. In spite of this,
many centers have all but abandoned CDU scan because of
concerns about technical adequacy and the difficulty in
interpretation of CDU scan results.6 CDU scan has been
reported to have a high false-positive rate for endoleak
when compared with CT scan,7 but what is less clear is the
rate of false-negative CT scan studies for the detection of
endoleak. Although aneurysm diameter at a standard refer-
ence point has been easier to follow with CT scan, some
Perigraft flow, also known as endoleak, from patent
branch vessels within the aneurysm sac or poor attachment
site seal is not an unexpected finding after endovascular
graft repair of abdominal aortic aneurysm (AAA).1-4 The
diagnosis and management of endoleak after endograft
implantation is the subject of great controversy and sub-
jectivity. This report focuses on the experience of a single
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Purpose: The purpose of this study was the demonstration of the value of color duplex ultrasound (CDU) scanning in
the detection of type I endoleak (T1EL) and type II endoleak (T2EL), the correlation of Doppler scan waveform pat-
tern to endoleak persistence or seal, and the description of the natural history of endoleak.
Methods: The study was a retrospective review of 83 patients who underwent periodic CDU scan and computed tomo-
graphic (CT) scan surveillance of the endograft and aneurysm sac after insertion of an aortic endograft for abdominal
aortic aneurysm (AAA). Forty-one patients (49%) with an endoleak at anytime in the follow-up period form the basis
of this report.
Results: T1EL was detected in all five patients with CDU and CT scans. T2EL was detected in 36 patients with CDU
scan as compared with 18 patients with CT scan. With CT scan, endoleak was not detected when CDU scan showed
no endoleak. Conversely, all CT scan–detected endoleaks were found with CDU scanning. The T2EL source artery was
identified with CT scan in seven patients, whereas the source was identified in all 36 patients with CDU scan. Endoleak
source did not correlate with outcome (seal or persistence). However, a to/fro Doppler scan waveform pattern was
associated with spontaneous T2EL seal in seven of 12 patients, and a monophasic or biphasic waveform was associated
with endoleak persistence in 14 of 17 patients (P = .023, with χ2 test). Thirteen of 36 T2ELs underwent spontaneous
seal by 6.2 ± 2.8 months. T2ELs without increasing AAA diameter were observed. Eight patients with persistent T2EL
present for more than 12 months did not undergo treatment. However, two patients underwent T2EL obliteration
with coils because of AAA sac enlargement. T1EL of the distal attachment site was the initial endoleak identified in five
patients, but seven patients harboring T2ELs had subsequent T1ELs develop. For the entire 83 patients, the combined
T1EL and T2EL prevalence rate was 20% of patients at a 6-month follow-up period, but this rate increased to 50%
after 24 months. The incidence rate of newly detected endoleaks and of spontaneous sealing was 24.4% at 12 months
and 12.5% in longer-term follow-up period.
Conclusion: CDU scan is effective in the identification of the type of endoleak, the delineation of the vessel involved,
and the hemodynamic information not available with any other testing method. Endoleaks have a dynamic natural his-
tory characterized by a variable onset with changing branch vessel involvement and spectral flow patterns. Periodic
long-term endograft surveillance with CDU scanning is necessary for following existing endoleaks and for detecting
new ones. Corroboration of these findings in larger multicenter prospective trials will be needed to determine whether
CDU scan analysis of endoleaks would be predictive of long-term success in endovascular AAA repair. (J Vasc Surg
2002;35:474-81.)
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investigators believe that endoleak detection would be
superior with CDU scan when compared with the tar-
nished “gold standard” of CT scan.7 The optimum use and
understanding of these technologies have been evolving.
The management of endoleak after endograft place-
ment also has been undefined. Traditionally, we and oth-
ers have opted for immediate intervention for type I
endoleak (T1EL; attachment site, both proximal and dis-
tal) because of the concern for aneurysm rupture.8 Other
centers have broadened this policy to include type II
endoleak (T2EL; branch vessel), and the general trend has
been towards aggressive treatment of these endoleaks.2
The best scheme for endoleak management has been, as
yet, undetermined. However, we believe that observation
and periodic reexamination with CT and CDU scanning
in all patients with T2EL is appropriate, unless there is evi-
dence of progressive AAA sac enlargement. This report
describes the hemodynamics, incidence, and natural his-
tory of endoleak after endovascular repair of AAA in a sin-
gle center with detailed CDU scan examination at all
follow-up time points.
MATERIALS AND METHODS
A retrospective review was undertaken of 83 patients of
the Norfolk Surgical Group who underwent endovascular
graft repair of AAA. The EVT-EGS/Guidant-Ancure
product (Menlo Park, Calif) was used in all cases. Patients
who underwent treatment before September 15, 1999,
were enrolled in Food and Drug Administration clinical
trials and underwent an Institutional Review
Board–approved informed consent process. CDU and CT
scan examinations were scheduled within 30 days and at 3,
6, and 12 months after surgery and then annually there-
Fig 1. Type II endoleak from lumbar artery as depicted with color duplex ultrasound scanning. A, Longitudinal view. B, Sagittal view.
C, Doppler scan waveform analysis results show that bidirectional (to/fro) pattern confirms endoleak.
A
B C
Fig 2. Type I endoleak (blue Doppler color shift) around endo-
graft limb (red Doppler color shift).
after. The aneurysm size, the type of endoleak (either not
detected, type I, or type II), and the identification of ves-
sels involved in the endoleak were obtained from these
studies. A T1EL has been defined as an incompetent seal at
one of the graft attachment sites, and a T2EL has the con-
tinuance of liquefied blood within the AAA sac because of
a patent branch vessel, such as the lumbar or inferior
mesenteric artery. Type III (fabric defect/interconnection)
and type IV (transgraft) endoleaks were not observed. The
CT scan protocol consisted of a 3-mm slice thickness and
a pitch of 2 mm, with a single detector helical scanner.
Three separate imaging examinations were performed: 1,
precontrast run for the identification of opacities; 2, a con-
trast run beginning 20 seconds after the start of an infusion
of 120 mL of Omnipaque 350 (Nycomed, Inc, Princeton,
NJ) at 4 mL/s; and 3, an immediate postcontrast run for
delayed imaging in search of late branch vessel endoleaks.
CT scan was diagnostic for endoleak if contrast was visual-
ized exterior to the endograft but within the aneurysm sac.
The CT scan studies were performed at the Sentara
Norfolk General Hospital, read by trained radiologists, and
reviewed by the authors. We adhered to the CDU proto-
col previously reported by Sato et al.9 CDU scan evidence
of an endoleak required the identification of perigraft
Doppler scan signals with color flow and was confirmed
with spectral analysis and mapping of the blood flow pat-
tern. In addition, a characterization of the Doppler scan
spectral analysis as biphasic, monophasic, or bidirectional
(to/fro) was obtained from the CDU scan studies as
described by Carter et al.10 Endoleak seal was the absence
of perigraft flow from the source vessel identified with prior
study results. An indeterminate examination was the inabil-
ity for the positive identification of the source vessel
responsible for producing the appearance of perigraft flow.
Statistical analysis of Doppler scan waveform types versus
endoleak seal were analyzed with χ2 test, with statistical
significance defined as a P value of less than .05.
RESULTS
The records of 83 patients who underwent treatment
with aortic aneurysm endograft from February 14, 1996,
to July 1, 2000, were available for review at a mean follow-
up period of 20.7 ± 16.8 months. A bifurcated endograft
was implanted in 63 patients, a tube endograft in 12
patients, and an aortoiliac endograft in eight patients.
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Since Food and Drug Administration approval of the
ANCURE device, only bifurcated grafts have been
implanted. Forty-two patients (51%) never had an
endoleak at any time in the follow-up period with CT and
CDU scan studies. The remaining 41 patients (49%) with
endoleaks identified at any time in the follow-up period
form the basis of this analysis. 
Color duplex ultrasound scan versus computed
tomographic scan. A total of 141 CDU scan examina-
tions were performed in 41 patients with endoleak. Eight
examinations were suboptimal because of gassy abdomen
or large abdominal girth. T2EL was initially detected with
CDU scan in 22 patients on the first postoperative exam-
ination, and the remaining 14 cases were found in subse-
quent follow-up studies. T2EL was detected with CT scan
in only 18 of these 36 patients (50%) with positive CDU
study results (Fig 1), and the source vessel of T2EL was
identified in only seven of 36 patients (19.4%; Table I).
Endoleak was not detected with CT scan when CDU
showed no endoleak; conversely, all CT scan–detected
endoleaks were found with CDU scan. T1EL was identi-
fied correctly with both CT and CDU scans (n = 5; Fig 2)
in every instance. There was no difference (P = .22) in the
rate of endoleak between tube grafts (four of 12) versus
bifurcated and aortoilliac grafts (37 of 71).
Spontaneous endoleak seal. At the last follow-up
CDU scan examination, 13 of 36 patients with previously
detected T2ELs were considered to have spontaneously
sealed endoleaks (Fig 3). The duration of a T2EL to seal
was 6.2 ± 2.8 months. No spontaneous closures occurred at
more than a 12-month follow-up period. The last observed
Doppler scan waveform pattern before seal was determined
to be to/fro in eight patients, monophasic in two patients,
biphasic in two patients, and undetermined in one patient.
The lumbar artery was identified as the source vessel in nine
instances. The inferior mesenteric artery was the source ves-
sel for endoleak in three cases and was the outflow vessel in
one case. The mean AAA sac diameter at last follow-up
examination decreased in the group with persistent T2EL
(–0.55 ± 0.33 cm) and was significantly different (P = .01)
versus the 42 patients without endoleak (–0.80 ± 0.68 cm)
but was not different (P = .07) in the 12 patients with spon-
taneous seal of T2EL (–0.63 ± 0.75 cm). The aneurysm sac
measurements in two patients with sealed endoleaks
changed +0.2 cm and were considered stable.
Table I. Comparison of type II endoleak source vessel identification with color duplex ultrasound scan versus com-
puted tomographic scan
T2EL (n = 36)
Lumbar IMA Lumbar and IMA Indeterminate
CDU (n = 36) 22 8 6 0
CT (n = 18) 4 3 0 11
T2EL, Type II endoleak; IMA, inferior mesenteric artery; CDU, color duplex ultrasound scan; CT, computed tomography.
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Type II endoleaks. Sixteen patients (Fig 4) were
identified as having persistent T2EL. However, six of
these patients had follow-up periods of less than 6 months
and did not undergo further analysis because some of
these endoleaks may close spontaneously. Ten patients
with persistent T2EL of 12 months duration or greater
underwent further analysis. An interventional procedure
to coil and occlude a branch vessel was needed in three
patients, all with biphasic waveform patterns: two patients
with longstanding T2EL had AAA sac enlargement
develop, and pronounced endograft wall motion with no
evidence of aneurysm sac thrombosis occurred in the third
patient. In seven patients with continuation of T2EL, the
waveform pattern was biphasic or monophasic in five.
AAA sac diameter had decreased by –0.65 ± 0.38 cm at
the last follow-up examination, therefore periodic CDU/
CT scan surveillance continues.
Waveform analyses. The Doppler scan spectral wave-
form pattern of the endoleak was assessed for verification
of the presence of endoleak when color flow was seen out-
side the endograft. Because the waveform patterns
changed frequently, the last identified T2EL Doppler scan
waveform pattern before closure was characterized into
either to/fro or biphasic/monophasic. The association of
endoleak occlusion with a to/fro spectral pattern on the
prior CDU scan evaluation suggests that flow pattern may
be important in the prediction of endoleak outcome (Fig
1). In this study, seven of 10 to/fro T2ELs sealed and 14
of 19 biphasic/monophasic T2ELs persisted (P = .023,
with χ2 test).
Type I endoleaks. T1ELs were the initial endoleaks
identified in five patients. However, 12 patients ultimately
had diagnoses of T1EL. Two patients had T1EL on the
first postoperative study results, and the remaining 10
patients had attachment site endoleak develop later. Seven
of these 10 patients had a T2EL on the initial postopera-
tive study results (Fig 5). In six of these seven patients,
two-vessel (inferior mesenteric/lumbar or lumbar/lum-
bar) endoleak involvement or biphasic/monophasic
Doppler scan signals in the sac were observed before the
appearance of T1EL. These same T2EL branch vessels
then showed flow reversal with blood exiting the sac in the
presence of the new T1EL. All T1ELs involved the distal
attachment site; no proximal attachment endoleaks were
detected. T1EL occurred at attachment sites in ectatic or
aneurysmal arteries in eight patients, through a ligated
iliac artery aneurysm in one patient, around a thrombosed
endograft limb in one patient, and around a limb
implanted into calcified plaque in one patient and was
undetermined in one patient. The treatments of these
attachment site endoleaks consisted of Wallstent/Wallgraft
(Boston Scientific Corp, Natick, Mass) insertion in six
Fig 3. Time line of patients with type II endoleaks that eventually sealed. L, Lumbar; IMA, inferior
mesenteric artery; T/F, to/fro; m, monophasic; bi, biphasic.
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patients, bifurcated endograft within tube endograft in
two patients, introduction of embolization coils in two
patients, and graft explant in one patient after a failed
attempt to seal the limb endoleak with a homemade graft-
covered stent. One patient’s endoleak was thought to have
spontaneously sealed.
Prevalence/incidence. For each follow-up interval,
the number of endoleaks in each category was compared
with the total number of patients in follow-up examination
at the same point in time (Fig 6). T1EL and T2EL com-
bined prevalence rate decreased to 20% by 6 months but
increased to 50% by 36 and 48 months (P = not significant).
Late T1ELs were caused by progression of aneurysmal dis-
ease at the distal graft attachment site, whereas the preva-
lence of late T2EL has been related to our policy of
ongoing follow-up examination of established T2EL in
nonenlarging AAAs. The number of either newly detected
or spontaneously sealed endoleaks at 12 months was 24.4%
(Table II). Spontaneous T2EL seals all occurred at 12
months or less of follow-up examination. New endoleaks,
both T1EL and T2EL, were identified 12.5% in the time
periods after 12 months of follow-up examination.
DISCUSSION
The natural history of endoleak after endovascular
repair of AAA is of great interest to physicians and patients
alike because there is considerable opinion and debate
regarding optimal management.11 Although the ideal test
for endoleak detection remains controversial,8,12 for the
past 5 years, we have chosen to rely on our private periph-
eral vascular laboratory with state-of-the-art CDU scan
equipment controlled by experienced technologists in
conjunction with CT scans and routine plain x-ray films.
The diagnostic accuracy of CDU scanning has been vali-
dated with correlation with angiography at our center
(unpublished data). In this report, our CDU scan surveil-
lance program is shown to reliably identify endoleak, to
discern branch flow from attachment site endoleak, to
identify the vessels feeding and exiting the AAA sac, and
to characterize the Doppler scan waveform pattern in most
Fig 4. Time line of patients with type II endoleaks that persisted or needed treatment. L, Lumbar; IMA,
inferior mesenteric artery; T/F, to/fro; m, monophasic; bi, biphasic.
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cases. This information in combination with the CT
scan–determined diameter measurement has facilitated the
identification of patients who need additional treatment
for endoleak versus those who can continue observation.
The comparison of the initial postoperative CDU scan
findings with subsequent study results indicates that
endoleak onset is highly variable and unpredictable. One
fifth of the patients in this study with negative initial study
results were later shown to have endoleak, and most
T2ELs were detected within a year of graft implant. One
explanation for the delayed appearance of endoleak may
be the difficulty of the initial examination, especially if the
patient’s abdomen is distended from ileus or painful from
groin or retroperitoneal incisions. Another possibility is
that the feeding vessels initially thrombose but over time
recanalize as a result of thrombolysis or conformational
changes. We cannot readily explain, however, the appear-
ance of endoleaks after several years of negative study
results.
Substantial controversy exists as to the appropriate
management of T2EL. It remains unclear whether a
T2EL should be observed and, if so, for how long.
Recent study results have shown the measurement of sys-
temic or near systemic blood pressure within the
aneurysm sac of patients with such endoleak.13 Some
physicians have advocated an aggressive policy to eradi-
cate endoleak after 3 months of observation,14 but this
policy is not without risk.15 Decreasing AAA sac size is
considered to be the hallmark of a successful endograft
implant and has occurred in a substantial number of
Table II. Incidence rate of spontaneous endoleak seal or newly detected endoleaks
No. of studies performed at each interval period
72 at 3 months 68 at 6 months 40 at 12 months 25 at 24 months 16 at 36 months 8 at 48 months
Spontaneous T2EL seal 2 (2.7%) 6 (8.8%) 5 (12.5%) 0 (0) 0 0
Onset of T1EL 3 (4.2%) 3 (4.4%) 1 (2.5%) 1 (4%) 1 (6.3%) 1 (12.5%)
Onset of T2EL 1 (1.4%) 2 (2.9%) 4 (10%) 1 (4%) 1 (6.3%) 0
T1EL, Type I endoleak; T2EL, type II endoleak.
Fig 5. Time line of any patient with type I endoleak. Note that type II endoleak vessel flow reverses (exits sac)
in presence of type I endoleak. L, Lumbar; IMA, inferior mesenteric artery; T/F, to/fro; m, monophasic; 
bi, biphasic.
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patients despite the presence of T2EL.16 Although we
continue to observe these endoleaks, provided the AAA
sac does not enlarge, we are concerned that with time a
biphasic endoleak involving both lumbar and inferior
mesenteric arteries may lead to an increase in sac size
necessitating intervention.
Makaroun et al17 have already reported the mid-term
fate of endoleaks and observed that most close sponta-
neously by 6 months. Our longer term results show that if
T2EL is to spontaneously seal, this should occur within a
year. This observation is also supported by the fact that no
spontaneous T2EL closure was observed beyond 12
months of follow-up examination. The presence of a
to/fro spectral Doppler scan waveform pattern is similar
to signals observed in the neck of a femoral false
aneurysm. This pattern suggests the absence of outflow as
compared with a monophasic/biphasic pattern. The
to/fro pattern preceded endoleak closure in most cases
and may possibly predict a benign course.
Direct arterial pressure within the aneurysm sac from
an attachment site leak is a significant matter, and treat-
ment should be definitive. In this series, T1EL was
detected 2% to 4% of the time in early postoperative stud-
ies, but with longer follow-up periods, it was more com-
mon by two to three fold. Many of the cases we observed
with T1ELs could be attributed to distal attachment site
placement in ectactic or aneurysmal arteries. However,
more than half of the cases were clearly first shown to
have a seal at the distal attachment site while at the same
time harboring a hemodynamically active T2EL feeding
the AAA sac. The observation of lumbar or inferior
mesenteric artery flow reversal (blood entering and then
later exiting the AAA sac) in the presence of T1EL is ver-
ification of T1EL development subsequent to a T2EL.
This phenomenon may possibly be related to the fact that
unsupported endograft limbs may not be able to stay in
full contact with the arterial wall in the presence of high
sac pressures from an active T2EL. Most late appearing
iliac limb T1ELs were successfully sealed with Wallstents
or Wallgrafts and also precipitated the seal of T2ELs.
Only a few reports in the literature directly compare
CT and CDU scans for the evaluation of endoleak. Our
methodology was to use single-detector helical CT scan
technology, which is a prevalent system available in most
modern hospitals, as compared with modern CDU scan
with spectral analysis by well-trained vascular technologists
Fig 6. Graph and table of prevalence rate (percent of patients) of endoleak at each follow-up interval.
T1EL, Type I endoleak; T2EL, type II endoleak.
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who performed an intensive search of the AAA sac that
lasted approximately 90 minutes. Our results have shown
the supremacy of CDU scan versus CT scan.
Wolf et al8 recently reported a head-to-head comparison
of 166 paired CT and CDU scan studies and found that
high-quality duplex ultrasound scan was comparable with CT
scan for the assessment of endoleak. An additional report
from d’Audiffret et al5 in France drew similar conclusions
from 211 paired studies. An important distinction concern-
ing methodology and use of technology must be clarified in
defining the CT scan “gold standard.” The Stanford group
used high-quality CDU scan and compared it with spiral CT
scan with an addition of intensive post–CT scan processing
on a computer workstation formatting a 3-dimensional
reconstruction, shaded surface display, maximal intensity pro-
jection, and curved planar reformation.18 This process of CT
scan angiography is extremely labor intensive and is reported
to take 2 to 3 hours with skilled technicians. With the best
available CT scan technology, they found that CDU scan was
comparable with CT scan angiography. Our French col-
leagues, again, used state-of-the-art two-detector spiral CT
scanning and compared results with four physicians trained in
vascular medicine and ultrasound scan with CDU scanning
with scan times of 20 minutes. Our ultrasound scan times
were considerably longer, which relates our desire for inten-
sive interrogation of the aneurysm sac for the discovery of all
endoleaks and characterized waveform patterns and the elu-
cidation of the hemodynamics and flow patterns within the
sac. Many consider CT scan the “gold standard,” but tech-
nology and methodology are variable. With the proper train-
ing and technique, widely available peripheral vascular
laboratories with CDU scan equipment may simply be a
more accurate and practical method for endoleak detection
and monitoring when compared with spiral CT scan.
CONCLUSION
CDU scan is effective in the identification of the type
of endoleak and the delineation of the vessel(s) involved
and provides hemodynamic information not available with
any other testing method. In our experience, CDU scan is
superior to CT scan in the detection and characterization
of endoleaks. Endoleaks have a dynamic natural history
characterized by a variable onset with changing branch
vessel involvement and spectral flow patterns. Because
endoleak is seen in 50% of studies after 2 years of postop-
erative follow-up examination, periodic long-term endo-
graft surveillance with CDU scan is necessary to follow
existing endoleaks and to detect new ones. Long-term
endoleak surveillance is safe because AAA sac enlargement
with rupture did not occur. Corroboration of these find-
ings by other investigators is needed to determine whether
CDU scan analysis of endoleaks is predictive of long-term
success in endovascular AAA repair.
We thank Courtney Nelms, BS, RVT, RDMS, Felicia
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and contributions.
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